Exelixis
EXEL
#1762
Rank
HK$87.70 B
Marketcap
HK$325.80
Share price
-0.71%
Change (1 day)
19.16%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company